PT Tempo Scan Pacific Tbk (PEXXF) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
PEXXF representa a PT Tempo Scan Pacific Tbk, una empresa del sector Healthcare con un precio de $ (capitalización de mercado 0). Calificado con 47/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 18 mar 2026PT Tempo Scan Pacific Tbk (PEXXF) Resumen de Asistencia Médica y Tuberías
PT Tempo Scan Pacific Tbk, an Indonesian-based company, manufactures and distributes pharmaceuticals, consumer products, and cosmetics, leveraging a strong brand portfolio including Bodrex and Marina, and a wide distribution network to serve both domestic and international markets within the healthcare and personal care sectors.
Tesis de Inversión
PT Tempo Scan Pacific Tbk presents a compelling investment case based on its established market position, diverse product portfolio, and extensive distribution network. The company's attractive P/E ratio of 7.51 and a high dividend yield of 8.00% suggest potential value for investors. A profit margin of 11.0% and gross margin of 37.2% reflect solid profitability. Growth catalysts include expanding its product lines and penetrating new international markets. However, investors may want to evaluate the risks associated with operating in a competitive market and potential regulatory changes in the pharmaceutical and consumer goods industries. The company's beta of 0.60 indicates lower volatility compared to the overall market.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market Cap of $0.46B indicates a mid-sized company with potential for growth.
- P/E ratio of 7.51 suggests the company may be undervalued compared to its earnings.
- Profit Margin of 11.0% demonstrates efficient operations and profitability.
- Gross Margin of 37.2% reflects the company's ability to manage production costs effectively.
- Dividend Yield of 8.00% provides a significant return for investors, indicating a commitment to shareholder value.
Competidores y Pares
Fortalezas
- Strong brand recognition in Indonesia.
- Extensive distribution network.
- Diverse product portfolio.
- Established market position.
Debilidades
- Dependence on the Indonesian market.
- Limited international presence compared to global competitors.
- Potential vulnerability to regulatory changes.
- Exposure to currency fluctuations.
Catalizadores
- Upcoming: Potential new product launches in the pharmaceutical and consumer goods segments within the next 12-18 months.
- Ongoing: Expansion of distribution network in Southeast Asia to increase market reach.
- Ongoing: Investments in research and development to drive innovation and product differentiation.
- Upcoming: Potential partnerships with e-commerce platforms to boost online sales.
- Ongoing: Government initiatives to improve healthcare access in Indonesia.
Riesgos
- Potential: Increasing competition from local and international players in the pharmaceutical and consumer goods industries.
- Potential: Regulatory changes in the pharmaceutical and consumer goods sectors that could impact profitability.
- Potential: Economic downturns in Indonesia and other key markets that could reduce consumer spending.
- Ongoing: Currency fluctuations that could affect the company's financial performance.
- Ongoing: Risks associated with operating in the OTC market, including limited liquidity and disclosure.
Oportunidades de crecimiento
- Expanding Product Lines: PT Tempo Scan Pacific Tbk has the opportunity to expand its product lines within the pharmaceutical and consumer goods segments. By investing in research and development, the company can introduce new products that cater to evolving consumer needs and preferences. The market for innovative healthcare and personal care products is growing, presenting a significant opportunity for PT Tempo Scan Pacific Tbk to increase its market share. This expansion can be achieved within the next 2-3 years with sufficient investment in R&D.
- Penetrating New International Markets: PT Tempo Scan Pacific Tbk can leverage its existing distribution network to penetrate new international markets. Southeast Asia, in particular, offers significant growth potential due to its large population and increasing demand for healthcare and consumer goods. By tailoring its products to local preferences and establishing strategic partnerships, the company can successfully expand its international presence. This expansion could begin within the next year, focusing initially on neighboring countries.
- Leveraging E-commerce Platforms: The increasing adoption of e-commerce in Indonesia and other Southeast Asian countries presents a significant growth opportunity for PT Tempo Scan Pacific Tbk. By partnering with leading e-commerce platforms and developing its own online sales channels, the company can reach a wider customer base and increase its sales. The e-commerce market in Indonesia is projected to grow significantly in the coming years, making this a strategic area for investment. This initiative can be implemented within the next 6-12 months.
- Focusing on Herbal and Natural Products: With growing consumer interest in natural and herbal products, PT Tempo Scan Pacific Tbk can capitalize on this trend by expanding its range of herbal and natural remedies. By leveraging its existing brands and distribution network, the company can effectively market these products to health-conscious consumers. The market for herbal and natural products is expanding rapidly, presenting a significant opportunity for PT Tempo Scan Pacific Tbk to increase its market share. This can be achieved through targeted marketing campaigns and product development over the next 1-2 years.
- Strengthening Distribution Network: PT Tempo Scan Pacific Tbk can further strengthen its distribution network by investing in logistics and infrastructure. By improving its supply chain efficiency and expanding its distribution reach, the company can ensure that its products are readily available to customers across Indonesia and other markets. A robust distribution network is crucial for maintaining a competitive edge in the consumer goods and pharmaceutical industries. This ongoing effort will solidify the company's market position.
Oportunidades
- Expanding into new international markets.
- Developing new products and formulations.
- Leveraging e-commerce platforms.
- Capitalizing on the growing demand for herbal and natural products.
Amenazas
- Increasing competition from local and international players.
- Changing consumer preferences.
- Economic downturns in Indonesia and other markets.
- Regulatory challenges and compliance costs.
Ventajas competitivas
- Strong brand recognition in Indonesia and other markets.
- Extensive distribution network across Indonesia.
- Diverse product portfolio spanning pharmaceuticals, personal care, and cosmetics.
- Established relationships with retailers and distributors.
Acerca de PEXXF
PT Tempo Scan Pacific Tbk, founded in 1970 and headquartered in Jakarta, Indonesia, has evolved into a prominent player in the pharmaceuticals, personal care, and distribution services industries. Originally known as PT Scanchemie, the company has grown into a diverse conglomerate with a significant presence in Indonesia and internationally. Its operations are divided into three main segments: Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services. The Pharmaceuticals segment focuses on the manufacturing and trading of pharmaceutical products and medical devices. The Consumer Products and Cosmetics segment produces a wide range of personal care items, cosmetics, and household products. These products are sold under well-known brands such as Bodrex, Oskadon, Marina, and MY BABY. The Distribution Services segment supports the company's operations through warehousing, freight forwarding, and marketing activities. PT Tempo Scan Pacific Tbk is a subsidiary of PT Bogamulia Nagadi, which provides a stable ownership structure. The company's commitment to research and development, combined with its extensive distribution network, positions it as a key player in the Indonesian market.
Qué hacen
- Manufactures and trades pharmaceutical products and medical devices.
- Produces and distributes personal care items, cosmetics, and household products.
- Sells products under brands like Bodrex, Marina, and MY BABY.
- Provides warehousing and freight forwarding services.
- Engages in advertising and promotion activities.
- Conducts research and development for new products and formulations.
- Offers information technology and communication network systems services.
- Procures, distributes, and markets products.
Modelo de Negocio
- Manufacturing and selling pharmaceutical products and medical devices.
- Producing and distributing consumer products, cosmetics, and household items.
- Providing distribution and logistics services to support its operations.
- Generating revenue through a diverse portfolio of brands and products.
Contexto de la Industria
PT Tempo Scan Pacific Tbk operates in the competitive pharmaceutical and consumer goods industries in Indonesia and internationally. The Indonesian pharmaceutical market is experiencing growth driven by increasing healthcare awareness and government initiatives to improve access to healthcare. The consumer goods sector is also expanding due to rising disposable incomes and changing consumer preferences. PT Tempo Scan Pacific Tbk competes with both local and international players, including AIHLF, CCHWF, CKDXF, DFHL, and ORRRY. The company's established brands and distribution network provide a competitive advantage in this dynamic market.
Clientes Clave
- Consumers in Indonesia and international markets.
- Retailers and distributors who sell PT Tempo Scan Pacific Tbk's products.
- Hospitals and clinics that use the company's pharmaceutical products.
- E-commerce platforms and online retailers.
Finanzas
Gráfico e información
Precio de la acción de PT Tempo Scan Pacific Tbk (PEXXF): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para PEXXF.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para PEXXF.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para PEXXF.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de PEXXF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: I Made Dharma Wijaya
CEO
I Made Dharma Wijaya serves as the CEO of PT Tempo Scan Pacific Tbk, leading a large workforce of 4545 employees. His background encompasses extensive experience in the consumer goods and pharmaceutical industries. He has held various leadership positions within PT Tempo Scan Pacific Tbk, contributing to the company's strategic planning and operational efficiency. His expertise includes market analysis, product development, and distribution management. He is committed to driving innovation and growth within the company.
Historial: Under I Made Dharma Wijaya's leadership, PT Tempo Scan Pacific Tbk has maintained its strong market position and expanded its product portfolio. He has overseen the implementation of key strategic initiatives, including investments in research and development and the expansion of the company's distribution network. His focus on operational excellence has contributed to improved profitability and efficiency. He has also played a key role in fostering a culture of innovation and collaboration within the company.
Información del mercado OTC de PEXXF
The OTC Other tier represents the lowest tier of the OTC market, indicating that PT Tempo Scan Pacific Tbk may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure.
- Low liquidity and high price volatility.
- Potential for fraud or manipulation.
- Lack of regulatory oversight.
- Higher risk of delisting or going out of business.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's liquidity and trading volume.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Confirm the legitimacy of the company's operations and assets.
- Established operating history since 1970.
- Presence in the pharmaceutical and consumer goods industries.
- Recognizable brands such as Bodrex and Marina.
- Subsidiary of PT Bogamulia Nagadi.
- Employs a large workforce of 4545 employees.
Lo Que los Inversores Preguntan Sobre PT Tempo Scan Pacific Tbk (PEXXF)
¿Cuáles son los factores clave para evaluar PEXXF?
PT Tempo Scan Pacific Tbk (PEXXF) actualmente tiene una puntuación IA de 47/100, indicando puntuación baja. Fortaleza clave: Strong brand recognition in Indonesia.. Riesgo principal a monitorear: Potential: Increasing competition from local and international players in the pharmaceutical and consumer goods industries.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de PEXXF?
PEXXF actualmente puntúa 47/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de PEXXF?
Los precios de PEXXF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre PEXXF?
La cobertura de analistas para PEXXF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en PEXXF?
Las categorías de riesgo para PEXXF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Increasing competition from local and international players in the pharmaceutical and consumer goods industries.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de PEXXF?
La relación P/E para PEXXF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está PEXXF sobrevalorada o infravalorada?
Determinar si PT Tempo Scan Pacific Tbk (PEXXF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de PEXXF?
PT Tempo Scan Pacific Tbk (PEXXF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Limited analyst coverage for PEXXF due to its OTC listing.
- Financial data based on available information and may not be fully comprehensive.